Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2024-01-22 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
关于使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by Wuxi Jinghai Amino Acid Co., Ltd. regarding the use of raised funds to replace self-raised funds previously invested in projects and paid issuance expenses. It includes details about the fundraising, approvals by the board and supervisory committee, independent directors' opinions, sponsor institution's verification, and an accountant's verification report. The document is relatively short (3659 characters) and primarily serves as a formal disclosure of a financing and fund usage update rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. The content focuses on the company's capital management and compliance with regulatory requirements related to the use of raised funds. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-01-22 Chinese
利润分配管理制度
Governance Information Classification · 95% confidence The document is titled '利润分配管理制度' which translates to 'Profit Distribution Management System'. It details the company's policies and procedures regarding profit distribution, including dividend policies, conditions for cash and stock dividends, and the approval process involving the board and shareholders. The document includes voting results from a board meeting and mentions submission to a shareholders' meeting. It is a detailed policy document rather than a report of financial results or an announcement of voting results. The length is 3650 characters, which is relatively short but the content is substantive and policy-focused. It does not contain financial statements or earnings data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a voting result announcement (DVA) because it does not report final shareholder vote outcomes but rather the policy itself. It is not a regulatory filing or announcement of a report. The document fits best under Governance Information (CGR) as it details internal rules and governance practices related to profit distribution and dividend policy.
2024-01-22 Chinese
第三届监事会第二十次会议
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 20th meeting of the third Supervisory Board of Wuxi Jinghai Amino Acid Co., Ltd. It details meeting attendance, agenda items, voting results, and references related announcements on the Beijing Stock Exchange information disclosure platform. The content focuses on supervisory board decisions regarding adjustments to fundraising investment projects, use of raised funds, and cash management proposals. There is no financial statement, earnings data, or detailed report content. The document is an official meeting resolution announcement rather than a full report or financial filing. Given the nature of the content and the formal announcement of supervisory board meeting resolutions, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. The document length is short (2147 characters), and it does not contain financial statements or detailed financial analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a Board/Management Information filing since it does not announce changes in board or management personnel. Therefore, the classification is RNS with high confidence.
2024-01-22 Chinese
无锡晶海氨基酸股份有限公司关于以募集资金置换预先投入募投项目及支付发行费用的自筹资金的专项说明的鉴证报告
Regulatory Filings
2024-01-22 Chinese
关于使用部分募集资金向全资子公司出资及提供借款实施募投项目的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by Wuxi Jinghai Amino Acid Co., Ltd. regarding the use of part of the raised funds to invest in and provide loans to its wholly-owned subsidiary for implementing a fundraising investment project. It includes details about the fundraising, board and supervisory approvals, independent director opinions, and the regulatory compliance of the fund usage. The document is a formal disclosure about capital usage and financing activities related to the company's fundraising proceeds. It does not contain financial statements or quarterly/annual financial results, nor is it a report or transcript. It is an update on capital/financing activities, specifically the use of raised funds for investment and loans to a subsidiary. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 3388 characters, which is consistent with an announcement rather than a full report.
2024-01-22 Chinese
独立董事关于第三届董事会第二十二次会议相关事项的独立意见
Capital/Financing Update Classification · 95% confidence The document is an independent directors' opinion on several proposals related to the use and management of raised funds by the company Wuxi Jinghai Amino Acid Co., Ltd. It discusses adjustments to investment amounts, use of raised funds to replace self-raised funds, cash management of idle raised funds, and use of funds to invest in subsidiaries. The document references compliance with relevant laws and regulations and approval procedures. It is not a full financial report, earnings release, or management discussion. It is also not a simple announcement of a report but an independent opinion related to board meeting decisions on capital use. This fits best under Capital/Financing Update (CAP) as it deals with fundraising and capital usage updates.
2024-01-22 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.